PetVivo Holdings, Inc.
PETVW
PetVivo Holdings, Inc. operates as a veterinary biotechnology and biomedical... PetVivo Holdings, Inc. operates as a veterinary biotechnology and biomedical device enterprise, dedicated to the development, strategic licensing, and commercialization of innovative medical instruments and biomaterials. Its mission is to address diverse afflictions and maladies impacting animal health. The company's premier offering is Kush, an injectable solution for joints that veterinarians administer to mitigate the effects of osteoarthritis and mobility impairment in canine and equine patients. Furthermore, PetVivo's future product roadmap encompasses 17 distinct therapeutic devices, poised for both animal and human clinical applications. The firm maintains its corporate headquarters in Minneapolis, Minnesota.
